Goodman Financial’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-150,859
| Closed | -$9.31M | – | 48 |
|
|
2022
Q3 | $9.31M | Buy |
150,859
+12,698
| +9% | +$783K | 3.12% | 7 |
|
|
2022
Q2 | $8.54M | Buy |
138,161
+4,886
| +4% | +$302K | 2.83% | 16 |
|
|
2022
Q1 | $7.92M | Buy |
133,275
+3,449
| +3% | +$205K | 2.25% | 28 |
|
|
2021
Q4 | $9.43M | Buy |
129,826
+4,241
| +3% | +$308K | 2.47% | 20 |
|
|
2021
Q3 | $8.77M | Buy |
125,585
+4,698
| +4% | +$328K | 2.4% | 16 |
|
|
2021
Q2 | $8.32M | Buy |
120,887
+10,261
| +9% | +$707K | 2.55% | 21 |
|
|
2021
Q1 | $7.15M | Buy |
110,626
+9,635
| +10% | +$623K | 2.29% | 24 |
|
|
2020
Q4 | $5.88M | Buy |
100,991
+6,122
| +6% | +$357K | 2.05% | 26 |
|
|
2020
Q3 | $6M | Buy |
94,869
+1,474
| +2% | +$93.1K | 2.79% | 16 |
|
|
2020
Q2 | $7.19M | Sell |
93,395
-290
| -0.3% | -$22.3K | 3.59% | 11 |
|
|
2020
Q1 | $7M | Sell |
93,685
-582
| -0.6% | -$43.5K | 4.28% | 4 |
|
|
2019
Q4 | $6.13M | Buy |
94,267
+1,012
| +1% | +$65.8K | 2.68% | 23 |
|
|
2019
Q3 | $5.91M | Buy |
93,255
+1,484
| +2% | +$94K | 2.96% | 19 |
|
|
2019
Q2 | $6.2M | Buy |
91,771
+3,216
| +4% | +$217K | 3.11% | 19 |
|
|
2019
Q1 | $5.76M | Buy |
88,555
+2,370
| +3% | +$154K | 2.93% | 21 |
|
|
2018
Q4 | $5.39M | Buy |
86,185
+614
| +0.7% | +$38.4K | 2.92% | 21 |
|
|
2018
Q3 | $6.61M | Buy |
85,571
+638
| +0.8% | +$49.3K | 3.21% | 16 |
|
|
2018
Q2 | $6.02M | Buy |
84,933
+5,658
| +7% | +$401K | 2.71% | 23 |
|
|
2018
Q1 | $5.98M | Buy |
+79,275
| New | +$5.98M | 2.81% | 17 |
|